Extending the Limits of Quantitative Proteome Profiling with Data-independent Acquisition and Application to Acetaminophen-treated Three-dimensional Liver Microtissues
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
The data-independent acquisition (DIA) approach has recently been introduced as a novel mass spectrometric method that promises to combine the high content aspect of shotgun proteomics with the reproducibility and precision of selected reaction monitoring. Here, we evaluate, whether SWATH-MS type DIA effectively translates into a better protein profiling as compared with the established shotgun proteomics. We implemented a novel DIA method on the widely used Orbitrap platform and used retention-time-normalized (iRT) spectral libraries for targeted data extraction using Spectronaut. We call this combination hyper reaction monitoring (HRM). Using a controlled sample set, we show that HRM outperformed shotgun proteomics both in the number of consistently identified peptides across multiple measurements and quantification of differentially abundant proteins. The reproducibility of HRM in peptide detection was above 98%, resulting in quasi complete data sets compared with 49% of shotgun proteomics. Utilizing HRM, we profiled acetaminophen (APAP)(1)-treated three-dimensional human liver microtissues. An early onset of relevant proteome changes was revealed at subtoxic doses of APAP. Further, we detected and quantified for the first time human NAPQI-protein adducts that might be relevant for the toxicity of APAP. The adducts were identified on four mitochondrial oxidative stress related proteins (GATM, PARK7, PRDX6, and VDAC2) and two other proteins (ANXA2 and FTCD). Our findings imply that DIA should be the preferred method for quantitative protein profiling.
Proteomic Analyses of Clots Identify Stroke Etiologies in Patients Undergoing Endovascular Therapy.
Kim T, Jung J, Kim Y, Yoon B, Han D, Ko S CNS Neurosci Ther. 2025; 31(3):e70340.
PMID: 40079446 PMC: 11904956. DOI: 10.1111/cns.70340.
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P Cancers (Basel). 2025; 17(5).
PMID: 40075679 PMC: 11899103. DOI: 10.3390/cancers17050832.
Biomarker Profile in Peripheral Blood Cells Related to Alzheimer's Disease.
Lomi M, Geraci F, Del Seppia C, Dolciotti C, Del Carratore R, Bongioanni P Mol Neurobiol. 2025; .
PMID: 40063315 DOI: 10.1007/s12035-025-04767-y.
Humphries E, Hains P, Robinson P ACS Omega. 2025; 10(7):6891-6900.
PMID: 40028131 PMC: 11865994. DOI: 10.1021/acsomega.4c09289.
Krawczyk-Ozog A, Stachowicz A, Szoniec G, Batko J, Stachyra K, Bolechala F Sci Rep. 2025; 15(1):7238.
PMID: 40021668 PMC: 11871314. DOI: 10.1038/s41598-025-89255-y.